Biohit Oyj (HEL:BIOBV)
Finland · Delayed Price · Currency is EUR 2.680
-0.020 (-0.74%)
Aug 7, 2026, 5:26 PM EET
Biohit Oyj Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 41 | 56 | 35 | 28 | 24 | 28 | |
Market Cap Growth | -7.12% | 61.30% | 22.03% | 20.61% | -14.44% | -26.01% |
Enterprise Value | 39.25 | 54.13 | 31.61 | 25.92 | 22.44 | 26.73 |
Last Close Price | 2.68 | 3.69 | 2.29 | 1.89 | 1.57 | 1.84 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 13.54 | 20.50 | 13.47 | 15.71 | 39.25 | - |
Forward PE | 15.76 | 23.81 | 14.54 | 17.14 | - | - |
PS Ratio | 2.53 | 3.57 | 2.43 | 2.18 | 2.16 | 2.95 |
PB Ratio | 2.52 | 3.75 | 2.85 | 3.02 | 3.17 | 3.78 |
P/TBV Ratio | 2.66 | 3.99 | 2.98 | 3.09 | 3.19 | 3.85 |
P/FCF Ratio | - | - | 188.95 | 43.56 | 13.20 | - |
P/OCF Ratio | - | - | 59.33 | 31.58 | 12.78 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.43 | 3.45 | 2.21 | 1.98 | 2.05 | 2.86 |
EV/EBITDA Ratio | 10.33 | 15.72 | 10.91 | 11.84 | 13.94 | 52.61 |
EV/EBIT Ratio | 12.27 | 18.67 | 12.36 | 14.20 | 19.88 | - |
EV/FCF Ratio | - | - | 171.78 | 39.63 | 12.54 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.07 | 0.08 | 0.02 | 0.05 | 0.13 | 0.03 |
Debt / EBITDA Ratio | 0.37 | 0.46 | 0.20 | 0.32 | 0.59 | 0.44 |
Debt / FCF Ratio | - | - | 3.19 | 1.07 | 0.53 | - |
Net Debt / Equity Ratio | -0.01 | -0.13 | -0.26 | -0.27 | -0.16 | -0.12 |
Net Debt / EBITDA Ratio | -0.05 | -0.57 | -1.09 | -1.17 | -0.73 | -1.73 |
Net Debt / FCF Ratio | 0.10 | 1.43 | -17.16 | -3.93 | -0.66 | 1.85 |
Asset Turnover | 0.80 | 0.89 | 1.01 | 1.09 | 1.06 | 0.92 |
Inventory Turnover | 6.40 | 5.36 | 5.15 | 5.10 | 4.60 | 4.17 |
Quick Ratio | 1.38 | 1.98 | 2.31 | 2.42 | 1.70 | 1.78 |
Current Ratio | 2.31 | 2.56 | 3.63 | 3.87 | 3.46 | 4.18 |
Return on Equity (ROE) | 19.91% | 19.90% | 23.77% | 21.93% | 8.14% | -18.75% |
Return on Assets (ROA) | 15.34% | 15.29% | 16.12% | 12.86% | 7.58% | -16.69% |
Return on Invested Capital (ROIC) | 19.38% | 24.52% | 28.83% | 23.43% | 12.31% | -23.52% |
Return on Capital Employed (ROCE) | 19.05% | 20.22% | 22.89% | 20.26% | 14.46% | -18.16% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 7.70% | 4.88% | 7.42% | 6.37% | 2.55% | - |
FCF Yield | - | - | 0.53% | 2.30% | 7.57% | - |
Buyback Yield / Dilution | -5.70% | -1.09% | -0.58% | -0.41% | -0.13% | 0.00% |
Total Shareholder Return | -5.70% | -1.09% | -0.58% | -0.41% | -0.13% | 0.00% |